Back to OTIC Stock Lookup

Otonomy (OTIC) – Major News

Feb 22, 2021 07:03 AM Otonomy (OTIC) Phase 3 Clinical Trial of OTIVIDEX in Patients with Meniere's Disease Did Not Achieve Primary Endpoint
May 6, 2019 05:04 PM Otonomy (OTIC) Tops Q1 EPS by 4c
May 9, 2018 04:44 PM Otonomy (OTIC) Misses Q1 EPS by 2c
Mar 8, 2018 04:26 PM Otonomy (OTIC) Misses Q4 EPS by 2c
Nov 8, 2017 04:51 PM Otonomy (OTIC) Tops Q3 EPS by 7c
Aug 30, 2017 07:02 AM Otonomy (OTIC) Says AVERTS-1 Phase 3 Trial for OTIVIDEX Missed Primary Endpoint
Mar 2, 2017 04:19 PM Otonomy (OTIC) Tops Q4 EPS by 5c
Jan 5, 2017 07:05 AM Otonomy (OTIC) Says Phase 3 Clinical Trial of OTIPRIO Met Primary Endpoint
Mar 7, 2016 04:15 PM Otonomy (OTIC) Tops Q4 EPS by 8c
Dec 11, 2015 07:31 AM Otonomy (OTIC) Announces Receipt of FDA Approval for OTIPRIO as Bilateral Otitis Media Treatment
Nov 10, 2015 04:23 PM Otonomy (OTIC) Reports Q3 Loss of $0.57/Share
Aug 12, 2015 04:08 PM Otonomy (OTIC) Tops Q1 EPS by 15c
May 21, 2015 04:10 PM Otonomy (OTIC) Announces OTO-104 Phase 2b Missed Primary Endpoint
May 12, 2015 04:42 PM Otonomy (OTIC) Tops Q1 EPS by 1c
Mar 18, 2015 04:16 PM Otonomy (OTIC) Tops Q4 EPS by 18c
Aug 13, 2014 10:37 AM Otonomy (OTIC) IPO Opens Sharply Higher

Back to OTIC Stock Lookup